Hybrisil | Methylprednisolone Acetate Gel while Breastfeeding

What is Hybrisil | Methylprednisolone Acetate Gel used for?

What are the risk associated with Hybrisil | Methylprednisolone Acetate Gel usage while breastfeeding? What precautions shall I take while using it in breastfeeding?

Methylprednisolone acetate while Breastfeeding

CAS Number: 83-43-2

Excreted into breast milk in non-significant amount with no problems reported in breastfed infants whose mothers were treated at a daily dose as high as 8 mg for a long time period. On long term treatments it would be advisable to wait for 2 - 4 hours until the next nurse to minimize the transfer of drug to breast milk. By waiting for 2 a 4 hours after a methylprednisolone megadose or a pulse therapy dose, the transfer into breast milk may be minimized as well. At high doses, intra-articular treatment with other steroid drugs (Triamcinolone) have transiently affected milk production. Steroids administered before delivery may delay initiation of phase II of Lactogenesis ("milk come in") and decrease milk production in the first postpartum week. Decreased production has been seen while taking Dexametasone. Steroid drugs are commonly used for Pediatric treatment with no side effects when infrequently used and for short-time periods. The American Academy of Pediatrics rates it compatible with breastfeeding. WHO Model List of Essential Medicines (2002) rates it compatible with breastfeeding

Methylprednisolone acetate while Breastfeeding

CAS Number: 83-43-2

Amounts of methylprednisolone in breastmilk are very low. No adverse effect have been reported in breastfed infants with maternal use of any corticosteroid during breastfeeding. With maternal intravenous doses of methylprednisolone 1 gram, fully breastfed infants would receive doses less than their daily cortisol output, and much less than a therapeutic dose on the day of infusion; accumulation of the drug does not occur in breastmilk with 3 consecutive daily doses. Avoiding breastfeeding during the infusion for as little as 2 hours after a 1 gram intravenous dose would markedly reduce infant exposure. Breastfeeding abstinence for 2 to 4 hours would further reduce the infant dose. Local injections, such as for tendinitis, would not be expected to cause any adverse effects in breastfed infants, but might occasionally cause temporary loss of milk supply.

I am nursing mother and I have already used Hybrisil | Methylprednisolone Acetate Gel, what should I do?

My health care provider has asked me to use Hybrisil | Methylprednisolone Acetate Gel, what to do?

If I am using Hybrisil | Methylprednisolone Acetate Gel, will my baby need extra monitoring?

Who can I talk to if I have questions about usage of Hybrisil | Methylprednisolone Acetate Gel in breastfeeding?